Division of Cancer Research

• 03/25/20
  A new function of protein SLFN11 to markedly improve the efficacy of anticancer drugs
• 03/12/20
  World's first prospective clinical test on a rare type of malignant lymphoma - Establishment of a standard treatment to improve the prognosis of patients -
• 02/26/20
  Discovery of novel treatment target and predictive markers of postoperative prognosis for lung cancer frequently observed in the Japanese (lung adenocarcinoma)
• 02/25/20
  Regulatory approval for ALK inhibitor alectinib for recurrent/refractory ALK-positive anaplastic large cell lymphoma
• 01/23/20
  How to keep boron inside cells during radiotherapy: a simple novel approach to cancer treatment
• 12/25/19
  The first discovery of a contribution of IL-34 to ovarian cancer malignancy, and its potential to be a target of a new treatment modality
• 12/19/19
  Genomic analysis for uterine adenomyosis identifies genetic mutations associated with the concurrence of disease onset and uterine endometriosis; elucidation of the pathogenesis of adenomyosis is expected
• 12/13/19
  Identification of genomic abnormalities involved in the onset and progression of dedifferentiated liposarcoma ― development of the database toward the implementation of precision medicine for soft tissue sarcomas
• 12/12/19
  7th US-Japan Workshop on Biomarkers for Cancer Early Detection ～Collaboration Across International Boundaries: It Takes a Village～
• 12/12/19
  New antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting; better study results than standard antiemetic therapy